» Articles » PMID: 26215436

Prognostic Significance of Increased Bone Marrow Microcirculation in Newly Diagnosed Multiple Myeloma: Results of a Prospective DCE-MRI Study

Overview
Journal Eur Radiol
Specialty Radiology
Date 2015 Jul 29
PMID 26215436
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Aim of this prospective study was to investigate prognostic significance of increased bone marrow microcirculation as detected by dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for survival and local complications in patients with multiple myeloma (MM).

Methods: We performed DCE-MRI of the lumbar spine in 131 patients with newly diagnosed MM and analysed data according to the Brix model to acquire amplitude A and exchange rate constant kep. In 61 patients a second MRI performed after therapy was evaluated to assess changes in vertebral height and identify vertebral fractures.

Results: Correlation analysis revealed significant positive association between beta2-microglobulin as well as immunoparesis with DCE-MRI parameters A and kep. Additionally, A was negatively correlated with haemoglobin levels and kep was positively correlated with LDH levels. Higher baseline kep values were associated with decreased vertebral height in a second MRI (P = 0.007) and A values were associated with new vertebral fractures in the lower lumbar spine (P = 0.03 for L4). Pre-existing lytic bone lesions or remission after therapy had no impact on the occurrence of vertebral fractures. Multivariate analysis revealed that amplitude A is an independent adverse risk factor for overall survival.

Conclusion: DCE-MRI is a non-invasive tool with significance for systemic prognosis and vertebral complications.

Key Points: • Qualitative parameters from DCE-MRI are correlated with established factors of disease activity • Increased marrow microcirculation might be a risk factor for loss of vertebral height and fractures • Amplitude A is an independent predictor for shortened overall survival.

Citing Articles

DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach.

Jamet B, Necib H, Carlier T, Frampas E, Bazin J, Desfontis P Cancer Imaging. 2024; 24(1):93.

PMID: 38992707 PMC: 11241781. DOI: 10.1186/s40644-024-00740-5.


Putrescence to Quintessence: An Atypical Presentation of Multiple Osteoporotic Spinal Fractures Masquerading as Multiple Myeloma.

Ojha V, Bahl V, Ramachandra S, Prashant A Cureus. 2022; 13(12):e20788.

PMID: 35141056 PMC: 8796275. DOI: 10.7759/cureus.20788.


Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.

Oprea-Lager D, Cysouw M, Boellaard R, Deroose C, de Geus-Oei L, Lopci E Front Oncol. 2021; 11:772530.

PMID: 34869009 PMC: 8640187. DOI: 10.3389/fonc.2021.772530.


Functional and molecular MRI of the bone marrow in multiple myeloma.

Koutoulidis V, Papanikolaou N, Moulopoulos L Br J Radiol. 2018; 91(1088):20170389.

PMID: 29393672 PMC: 6209491. DOI: 10.1259/bjr.20170389.


Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction.

Latifoltojar A, Hall-Craggs M, Bainbridge A, Rabin N, Popat R, Rismani A Eur Radiol. 2017; 27(12):5325-5336.

PMID: 28656463 PMC: 5674123. DOI: 10.1007/s00330-017-4907-8.


References
1.
Dutoit J, Vanderkerken M, Verstraete K . Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma. Eur J Radiol. 2013; 82(9):1444-52. DOI: 10.1016/j.ejrad.2013.04.012. View

2.
Hillengass J, Stieltjes B, Bauerle T, McClanahan F, Heiss C, Hielscher T . Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and diffusion-weighted imaging of bone marrow in healthy individuals. Acta Radiol. 2011; 52(3):324-30. DOI: 10.1258/ar.2010.100366. View

3.
Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A . Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res. 2007; 13(2 Pt 1):475-81. DOI: 10.1158/1078-0432.CCR-06-0061. View

4.
Engelhardt M, Terpos E, Kleber M, Gay F, Wasch R, Morgan G . European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica. 2014; 99(2):232-42. PMC: 3912952. DOI: 10.3324/haematol.2013.099358. View

5.
Hillengass J, Zechmann C, Nadler A, Hose D, Cremer F, Jauch A . Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma. Int J Cancer. 2008; 122(12):2871-5. DOI: 10.1002/ijc.23455. View